JP Morgan Losses Hits Futures

7:45 PM ET Thu, 10 May 2012

CNBC's Brian Shactman reports JP Morgan shares are down almost 7% in after-hours trading; Yahoo's CEO says he didn't provide the company with a resume; and shares of Arena Pharmaceuticals soar as an FDA advisory panel approves its obesity drug.